Clinical Trials Update: June 9, 2004

Gastroesophageal Reflux Disease (GERD) Rheumatoid Arthritis Asthma (Pediatric)

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Gastroesophageal Reflux Disease (GERD)

A research study to determine if an investigational medication can help people who have heartburn (gastroesophageal reflux disease, or GERD) symptoms and are taking proton pump inhibitor (PPI) therapy. Volunteers at least 18 who have GERD symptoms and have been taking PPI therapy for at least four weeks may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat70.html.

-----

Rheumatoid Arthritis

A research study to assess the safety and effectiveness of an investigational compound in patients with rheumatoid arthritis. Volunteers 18 to 80 who have had rheumatoid arthritis symptoms for at least 12 months and have been diagnosed with rheumatoid arthritis as defined by the American Rheumatism Association may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat132.html.

-----

Asthma (Pediatric)

A research study to evaluate the effectiveness and safety of an investigational medication in children between ages 6 and 12 with moderate to severe, persistent inadequately controlled allergic asthma. Volunteers who have been diagnosed with allergic asthma for more than one year, have experienced an asthma attack within one year, and who are currently using an asthma inhaler (corticosteroid) may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat442.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News